Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Type A vs Type B Alcoholism
NCT00124059Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- Mar 2003
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of quetiapine in alcohol dependence (4 arms), sponsored by University of Pennsylvania. Primary endpoints: TimeLine FollowBack for proportion of days abstinent at 13 weeks, TimeLine FollowBack for proportion of days of heavy drinking at 13 weeks and 1 more. Started Mar 2003; status: completed.
02
Drugs
quetiapine
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00124059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00124059.